A clinical update on the role of carfilzomib in the treatment of relapsed or refractory multiple myeloma.

Franken, B; van de Donk, N W C J; Cloos, J C; Zweegman, S; Lokhorst, H M.

Afiliación

Franken B; VU University Medical Center, Amsterdam, The Netherlands.
van de Donk NW; VU University Medical Center, Amsterdam, The Netherlands.
Cloos JC; VU medisch centrum School of Medical Sciences, Amsterdam, The Netherlands.
Zweegman S; VU medisch centrum School of Medical Sciences, Amsterdam, The Netherlands.
Lokhorst HM; VU medisch centrum School of Medical Sciences, DE Boelelaan 1117, Amsterdam, 1007 MB, The Netherlands.

Ther Adv Hematol ; 7(6): 330-344, 2016 Dec.

Article en En | MEDLINE | ID: mdl-27904737